Merav Bassan - Apr 14, 2025 Form 4/A - Amendment Insider Report for BiomX Inc. (PHGE)

Role
Chief Development Officer
Signature
/s/ Merav Bassan
Stock symbol
PHGE
Transactions as of
Apr 14, 2025
Transactions value $
$0
Form type
4/A - Amendment
Date filed
4/21/2025, 08:11 AM
Date Of Original Report
Apr 18, 2025
Previous filing
Sep 18, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHGE Common Stock Award $0 +79.6K $0.00 79.6K Apr 14, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHGE Common Stock Options - right to Buy Award $0 +95K $0.00 95K Apr 14, 2025 Common Stock 95K $0.54 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of 79,597 Restricted Stock Units ("RSUs"). The RSUs are immediately vested and convert into the Issuer's shares of common stock on a one-for-one basis.
F2 The options vest and become exercisable over four years, with 25% of the shares of common stock subject to the option vesting on April 14, 2026, and the reminder vesting in 12 equal quarterly installments over three years.

Remarks:

This amendment is being filed solely to correct an administrative error in Table II, Column 5. The number of derivative securities acquired was inadvertently reported under (D) of Column 5 instead of (A). No other changes have been made to the originally filed Form 4.